SARS-CoV-2, a new causative agent of Guillain-Barré syndrome? A. Esteban Molina, M. Mata Martínez, P. Sánchez Chueca, A. Carrillo López

SARS-CoV-2 reinfection I. Romera, K. Núñez, M. Calizaya, I. Baeza, R. Molina, J. Morillas

Early mortality risk stratification after SARS-CoV-2 infection D.J. Lundon, B.D. Kelly, S. Nair, D.M. Bolton, N. Kyprianou, P. Wiklund, A. Tewari